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Abstract:
Follistatin related gene (FLRG) has been previously identified from a chromosomal translocation observed in a B-cell chronic lymphocytic leukemia (B-CLL). FLRG (alternative names: follistatinrelated protein, FSRP / follistatin-like-3, FSTL3) is a secreted glycoprotein highly similar to follistatin. Like follistatin, FLRG is involved in the regulation of various biological effects through its binding to members of the transforming growth factor beta (TGFβ) superfamily such as activin A and myostatin. We have previously shown that TGFβ and activin A are potent inducers of FLRG transcriptional activation through the Smad proteins. Using a biochemical approach, we investigated whether tumor necrosis factor alpha (TNFα) could regulate FLRG expression since
TNFα plays a critical role in hematopoietic malignancies. We demonstrate that TNFα activates FLRG expression at the transcriptional level. This activation depends on a promoter region containing four 107-108 bp DNA repeats evolutionary conserved in primates. These repeats carry a strong phylogenetic signal, which is not very common among non-coding sequences. Each DNA repeat contains one TNFα responsive element (5'-GGGAGAG/TTCC-3') able to bind nuclear factor kappaB (NF-κB) transcription factors. We also show that TGFβ, through the Smad proteins, potentates the effect of TNFα on FLRG expression. This cooperation is unexpected since TGFβ and TNFα usually have opposite biological effects. In all, this work brings new insights in the understanding of FLRG regulation by cytokines and growth factors. It opens attractive perspectives of research that should allow us to better understand the role of FLRG during tumorigenesis.
Introduction
We previously reported the molecular characterization of a t(11;19)(q13;p13) translocation in a Bcell chronic lymphocytic leukemia (B-CLL) (Hayette et al 1998) . At the breakpoint on chromosome 19, we identified a new evolutionarily-conserved gene, FLRG (follistatin-related gene, also named Follistatin-related protein, FSRP / follistatin-like-3, FSTL3). It encodes a secreted glycoprotein highly similar to follistatin. As described for follistatin, FLRG physically interacts with members of the TGFβ (transforming growth factor beta) family such as activin A and myostatin to neutralize their biological effects (Bartholin et Tumor necrosis factor alpha (TNFα) has been characterized as a serum factor causing necrosis of tumors (Carswell et al 1975; Green et al 1976) . TNFα has been involved in numerous biological processes such as apoptosis, inflammation, viral replication and blood cells homeostasis (Aggarwal 2003; MacEwan 2002) . TNFα binds TNFR1 and TNFR2 (TNFα receptor one and two) to activate various signaling pathways such as NF-κB (nuclear factor kappaB), MAPK (mitogen-activated
protein kinases) or caspases pathways. The first characterized NF-κB member, NF-κB 1 (p50; p105), is a nuclear protein initially found as a kappa immunoglobulin enhancer interacting protein in cells that transcribed immunoglobulin light chain genes (Sen and Baltimore 1986a; Sen and Baltimore 1986b 
Material and methods

Cell culture
The human hepatocellular carcinoma cell line HepG2, and the mink lung epithelial cell line Mv1Lu
were obtained from the American Type Culture Collection (ATCC), and cultured in Dulbecco's modified Eagle's medium containing 10% fetal calf serum, 0.03% L-glutamine, 100 mg/ml penicillin and 100 mg/ml streptomycin sulfate.
Plasmids and deletion constructs
Various FLRG promoter fragments were cloned into the luciferase reporter plasmid pGL3-MLP containing a minimal promoter consisting of a TATA box and the initiator sequence of the adenovirus major late promoter (MLP) provided by JM Gauthier (Glaxo, Wellcome laboratory, Les
Ullis, France) as described in . FLRG promoter fragments specifically used in this study, (-3293/+6)Δ(κBx4), (κBx4) and (κBx1), were generated by PCR using pGL3-FLRG(-3293/+6)-MLP as a template and further cloned into pGL3-MLP. Δ(κBx4) deletion encompasses nucleotides -1925 to -1492 and κBx4 promoter fragment covers nucleotides -1940 to -1470. κBx1 fragment covers FLRG promoter from nucleotides -1599 to -1706 (H3 repeat, Fig. 3A ). In the κBx1-mut fragment, the κB site was mutated as described in paragraph 2.5. Mammalian expression vectors for Smad3 and Smad4 were provided by P ten Dijke (Ludwig Institute for Cancer Research, Uppsala, Sweden). Mammalian expression vectors encoding NF-κB 1 (p50) and Rel-A(p65) were provided by P Jalinot (Ecole Normale Supérieure, Lyon, France). IκB(A32-A36) expression vector was a gift from A Israel (Institut Pasteur, Paris, France). Expression vector encoding CA-IKK2 was obtained from B Baumann (Ulm University, Ulm, Germany).
Transient tranfections and reporter assays
HepG2 cells were cotransfected (Exgen 500, Euromedex, France) with the appropriate firefly luciferase reporter and pRL-CMV (Promega) as previously described . TNFα (10-20 ng/ml, R&D Systems) and TGFβ (10 ng/ml, R&D Systems) were added 24 hours after A C C E P T E D M A N U S C R I P T
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6 transfection and luciferase activity was assayed 48 hours after transfection ("Dual luciferase assay kit", Promega). The same amount of plasmid DNA was kept constant by the addition of "empty"
vectors. All the experiments were performed in triplicate, and the luciferase activity was normalized with regard to the renilla luciferase activity expressed by the pRL-CMV vector.
Northern blots
Total cellular RNA was purified by the acid guanidium thiocyanate-phenol-chloroform method. For northern blot analysis, 10 mg of total RNA were size-fractionated in formaldehyde-1.2% agarose gels and transferred onto nylon filters. The probes were radiolabeled (32. P-dCTP) using the Rediprime labeling kit (Amersham Pharmacia Biotech) and hybridized according to standard procedures. RNA integrity and equal loading was assessed by ethidium bromide staining of ribosomal 18S and 28S RNAs.
Electrophoresis mobility-shift assay (EMSA)
Nuclear proteins from Mv1Lu cells were treated for 30 minutes in the presence of TNFα (20 ng/ml) and/or TGFβ (10 ng/ml) and gel-shift assays were performed as previously described . Specifically, the wild type (wt-κBx1) and mutant (mut-κBx1) double-stranded DNA probes cover FLRG promoter from nucleotides -1599 to -1706 (H3 repeat, Fig. 3A ). In mut-κBx1 probe, the κB site was mutated (USE Mutagenesis kit, Amersham Pharmacia Biotech) into a Spe-I restriction enzyme site (wt 5'-GGGGAGATTCCC-3' to mut 5'-ACTAGT3-') to facilitate further identification of the mutant clones. The SBE (smad binding element) probe (5'-GGTCGAGAGCCAGACAAAAAGCCAGACATTTAGCCAGACAATCCCGCAAGAGGGCCG GGG-3') contains three Smad Binding Elements (underlined) (Dennler et al 1998) . For supershifts analysis, we used commercial rabbit polyclonal antibodies (Santa Cruz Biotechnology) directed against NF-κB 1 (p50) (#sc-114x), Rel-A(p65) (#sc-109x), Smad4 (#sc-7154x) and Oct1 (#sc-232x).
Sequence alignment and phylogenetic tree estimation
The four human repeats were first aligned using Clustal W (Thompson et al 1994) . Each repeat was then used as query in a BLAST search (Altschul et al 1990) to identify similar sequences among complete genomes. Three matches were found among Pan troglodytes (chimpanzee) genome and one among Macaca mulatta (rhesus macaque) genome. The eight sequences (4 in human + 3 in chimpanzee + 1 in macaque) were then aligned using Clustal W. A phylogenetic tree was estimated from this alignment using a Bayesian approach (software: MrBayes (Huelsenbeck and Ronquist 2001) and maximum likelihood approach (software: PHYML (Guindon and Gascuel 2003) ).
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Results
TNFα up-regulates FLRG expression at the transcriptional level
To investigate the ability of TNFα to modulate FLRG expression, we performed a northern-blot analysis using total RNA prepared from HepG2 cells treated or not with TNFα for 24 hours. This approach revealed a large increase in the level of the two FLRG RNA transcripts (2.5 and 1.2 kb) in response to TNFα (Fig. 1A) . We previously reported the cloning of a reporter construct containing TNFα treatment produces a 4-fold induction of luciferase activity, indicating an increase in de novo transcription of the FLRG promoter (Fig. 1B) . In contrast, the empty vector (pGL3-MLP) is not sensitive to TNFα (Fig. 1B) . In all, these results demonstrate that TNFα up-regulates FLRG expression at the transcriptional level.
Identification of TNFα-responsive elements in FLRG promoter
Identification of TNFα-responsive elements was allowed by the cloning of various FLRG promoter fragments into the pGL3-MLP reporter plasmid as previously described . 
Evolutionary history of the TNFα-responsive elements found within FLRG promoter
Computer assisted sequence analysis revealed that the FLRG promoter region (nucleotides 1920- 3B ). The alignment of the FLRG promoter sequences from human, chimpanzee and macaque, suggests that early primate genomes had only one repeat while unequal recombination increased the number of repeats during the course of evolution (Fig. 3B) . We next aligned these sequences and estimated a phylogenetic tree in order to better understand the origin of the four human repeats.
Two phylogenetic estimation methods that rely on sound statistical basis converged to the same tree, which is compatible with the well-known phylogeny of these primates (Fig. 3C ). The analysis of this tree suggests that three duplication events (d1, d2 and d3) occurred after the first speciation
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10 event (s1: macaque vs. (human, chimpanzee)) and before the second speciation event (s2: human vs. chimpanzee). The position of C4 and C5 in the tree indicates that these two repeats appeared after s2 (i.e., C4 and C5 are paralogous and both are orthologous to H4). C2 and C3 are absent in chimpanzee. According to the estimated phylogeny, these sequences were lost after s1.
Interestingly, this phylogeny is also compatible with the positions of the human and chimpanzee repeats on their chromosomes, i.e., the position of the tips in the tree is the same as the positions of the corresponding sequences on the genomes. Hence, while the method that is used to build the phylogeny ignores the position of the repeats on the chromosome, this information can be recovered from the phylogenic signal carried by these sequences. The chance that a random phylogeny with the same number of taxa displays such features is small. In all, it is very likely that the proposed phylogeny accurately describes the succession of duplications and speciation events that governed the evolution of these sequences.
Involvement of NF-κB transcription factors NF-κB1(p50) and Rel-A(p65) in TNFα-mediated FLRG activation
Having determined that FLRG promoter sensitivity to TNFα depended on a genomic DNA region containing four NF-κB binding sites, we then asked whether NF-κβ transcription factors NF- (Fig. 4C) . Interestingly, CA-IKK2 fails to activate pGL3-FLRG(κBx1-mut)-MLP reporter (Fig. 4C ). This latter result proves the functional relevance of one NF-κB binding site identified inside FLRG promoter.
Taken together, our results demonstrate that NF-κB transcription factors, NF-κB 1 (p50) and Rel-A(p65), are involved in the activation of FLRG promoter after TNFα treatment.
Binding of NF-κB1(p50) and Rel-A(p65) to FLRG promoter
We next investigated whether TNFα induced the binding of nuclear proteins to the NF-κB binding sites found within FLRG promoter. We performed a gel-shift assay using nuclear proteins prepared from cells treated or not with TNFα. We used radiolabeled DNA probes containing either wild-type (wt-κBx1) or mutated (mut-κBx1) NF-κB binding sites. These probes correspond to the H3 repeat (covering promoter region from nucleotides -1706 to -1599) (Fig. 3) . The migration of the wt-κBx1 probe appears to be shifted in the presence of nuclear proteins prepared from TNFα-treated cells (Fig. 5A, lines 1 and 2) . Intensity of this shifted band is dramatically reduced if we use the mutant probe (mut-κBx1) (Fig. 5A, lines 3 and 4) . This result shows that NF-κB binding sites found within FLRG promoter bind nuclear proteins after TNFα treatment. To further identify these nuclear proteins, we performed gel-supershift assays (Fig. 5B) . Antibodies against NF-κB 1 (p50) and Rel-
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A(p65) were added to the nuclear proteins prior incubation with the radiolabeled wt-κBx1 probe.
Gel separation revealed that NF-κB 1 (p50) and Rel-A(p65) antibodies respectively abrogates (Fig.   5B , line 5) and supershifts (Fig. 5B, line 6 ) the DNA-protein complex that is normally observed after TNFα treatment (Fig. 5B, line 2) . In contrast, antibodies against Smad4 and Oct1 used as negative controls do not impair the formation of this complex (Fig. 5B, lines 3 and 4) . These results indicate that TNFα controls the formation of an DNA-protein complex containing endogenous NF-κB transcription factors NF-κB 1 (p50) and Rel-A(p65).
TNFα cooperates with TGFβ to up-regulate FLRG expression
In a previous work, we demonstrated that TGFβ was a potent inducer of FLRG expression via the Smad proteins . Here, we examined whether TGFβ and TNFα had a synergistic effect on FLRG expression. Northern-blot analysis reveals that accumulation of FLRG transcripts after TGFβ+TNFα treatment is more pronounced than the accumulation observed in cells treated with TGFβ or TNFα alone (Fig. 6A ). Reporter tests reveal that TNFα and TGFβ alone produce a 5-fold induction of luciferase activity, whereas in combination, these two cytokines induce a 15-fold induction of luciferase activity (Fig. 6B) . These results indicate that TGFβ and TNFα act in synergy to activate FLRG transcription. We next assessed a possible functional interaction between NF-κB and Smads proteins (Fig. 6C) . Luciferase assays showed that overexpression of Smads (Smad3+Smad4) and NF-κB (p50+p65) respectively induce a 10-fold and a 2.5-fold induction of FLRG promoter. Interestingly, combined overexpression of Smad and NF-κB (Smad3+Smad4+p50+p65) proteins induces a 15-fold induction of FLRG promoter. This observation suggests that NF-κB and Smads act in cooperation to activate FLRG transcription. To explore the molecular mechanism supporting this cooperation, we performed gel-shift assays by using the wt-κBx1 probe and nuclear proteins prepared from cells cultured with TGFβ and/or TNFα (Fig. 6D, left panel) . Our results indicate that TGFβ neither induces the formation of a DNA-protein
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Another EMSA was performed in the same conditions with a probe containing three canonical Smad Binding Element or SBE (Fig. 6D, right NF-κB transcription factors (Rel-A (p65), NF-κB1 (p50), NF-κB2 (p52), c-Rel and Rel-B) bind DNA consensus site (5'-GGGRNNYYCC-3', N = any base, R = G or A, and Y = C or T) (Hayden and Ghosh 2004) . The three κB sites (5'-GGGAGATTCC-3') respectively found within the H2, H3
and H4 repeats perfectly match with the consensus sequence described above whereas the κB site found within the H1 repeat (5'-GGGAGAGTCC-3', degenerated base is underlined) contains one degenerated base (Fig. 3A) . Ancestors of these four human repeats are only found among chimpanzee and macaque genomes. These repeats carry a strong phylogenetic signal, which is not very common among non-coding sequences. This signal helped us to decipher the evolutionary origin of the human FLRG promoter. The presence of tandem repeats suggests that the structure of FLRG promoter is likely to be subject to frequent rearrangements (most probably due to unequal recombination events). The phylogenetic analysis of these primate sequences seems to confirm this hypothesis: losses and duplications observed in closely related primates clearly suggest fast rates of evolution. At the functional level, it will be of particular interest to investigate if there is a correlation between the number of tandem repeats and sensitivity to TNFα, and if we can observe polymorphisms affecting the number of tandem repeats in patients with malignant blood diseases.
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FLRG and follistatin are similar in many respects. Secreted FLRG and follistatin glycoproteins both interact with members of the TGFβ family such as activin A to neutralize their biological effects. So, it is tempting to speculate that in some malignancies, increased NF-κB activity would result in FLRG up-regulation to block the anti-proliferative effect of activin A.
We showed in a previous work that FLRG was a direct target gene of the Smad proteins in response to TGFβ . Here, we demonstrate that TGFβ cooperates with TNFα to activate FLRG transcription. The molecular mechanism of this cooperation is still unclear. Our results suggest that it neither involves the formation of a Smad/NF-κB protein complex at the NF-κB binding sites nor an increased DNA recruitment of NF-κB transcription factors. Indeed, in EMSA experiments, TGFβ does not impair the TNFα-induced complex that forms at the κB sites.
However, we cannot rule out the possibility that other NF-κB members (p52, c-Rel, Rel-B) may be involved in a Smad/NF-κB protein complex. It is also possible that NF-κB/Smad interaction complex would occur through the previously characterized Smad binding element (SBE) present within FLRG promoter . Further experiments will address these questions as well as the possible indirect mechanisms that could explain the synergic effect of TNFα and TGFβ to activate FLRG expression. From literature, several hypotheses can be proposed. The simplest explanation would be to consider that TGFβ and TNFα activate two very distinct signaling pathways (respectively Smad and NF-κB pathways) without a real biochemical connection. In contrast, Smad and NF-κB proteins, bound to their respective and distinct responsive elements, could physically interact at the chromatin level through the recruitment of shared transcriptional coactivators such as p300 (Kon et al 1999) . Alternatively, TGFβ could stimulate post-translational modifications of NF-κB factors to potentate their transcriptional activity (Schmitz et al 2001) . Interestingly, other genes have also been reported to be co-activated by TNFα and TGFβ such as type VII collagen (Kon et al 1999) and PAI-1 (Hou et al 2004) . Unfortunately, the functional significance of the co-activation of these genes by TGFβ and TNFα remains unclear as well.
In conclusion, this work brings new insights in the understanding of the modulation of FLRG expression by cytokines and growth factors. It opens attractive perspectives of research that should allow us to better understand the role of FLRG during tumorigenesis. shift assay (electrophoretic mobility shift assay) was performed using labeled probes containing the H3 repeat ( Figure 3A ) and nuclear proteins prepared from cells treated or not with TNFα. wt-κBx1
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and mut-κBx1 probes respectively contain a wild-type and a mutated NF-κB binding site. (B)
Antibodies against NF-κB 1 (p50) and Rel-A(p65) were used in supershift assays to detect the presence of NF-κB transcription factors in the DNA/protein complex that forms in response to
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